Lucas Moreno
0000-0002-0708-1670
Hospital Vall Hebron
13 papers found
Refreshing results…
Palliative care for children with central nervous system tumors: results of a Spanish multicenter study
Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo
Methodological advances in the discovery of novel neuroblastoma therapeutics
Neuronal Differentiation-Related Epigenetic Regulator ZRF1 Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In Vitro
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models
Initial Report on Spanish Pediatric Oncologic, Hematologic and Post Stem Cell Transplantation Patients During SARS-CoV-2 Pandemic
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectives
The challenge of defining “ultra-high-risk” neuroblastoma
Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer.
Missing publications? Search for publications with a matching author name.